| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |